A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
Clinical trial NCT03674866 · COMPLETED
Trial details
- NCT number
- NCT03674866
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-29
- Primary completion
- 2019-04-25
- Enrollment
- 662
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.